Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/4/2020
SIETES contiene 92957 citas

 
 
 1 a 20 de 50 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Ritchie A, Singanayagam A. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?. Lancet 2020:24 de marzo. [Ref.ID 103571]
2. Cita con resumen
Anónimo. Anti-inflammatoires non stéroïdiens: infections graves, fasciites cervicales. Prescrire 2014;34:832-3. [Ref.ID 98465]
3. Cita con resumen
Anónimo. Herbal medicines for osteoarthritis. Drug Ther Bull 2012;50:8-12. [Ref.ID 92099]
4. Cita con resumen
Khemasuwan D, Chae YK, Gupta S, Carpio A, Yun JH, Neagu S, Lucca AB, Valsecchi ME, Mora JI. Dose-related effect of statins in venous thrombosis risk reduction. Am J Med 2011;124:852-9. [Ref.ID 91113]
5. Cita con resumen
De Caterina R, Ruigómez A, García Rodríguez LA. Long-term use of anti-inflammatory drugs and risk of atrial fibrillation. Arch Intern Med 2010;170:1450-5. [Ref.ID 89347]
6. Cita con resumen
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010;67:446-57. [Ref.ID 88168]
7. Cita con resumen
Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009;373:1905-17. [Ref.ID 85954]
8. Cita con resumen
Faigen N. Off-label Avastin linked to 36 eye inflammation cases in Canada. Scrip 2009;3427:22. [Ref.ID 85013]
9. Cita con resumen
Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome?. Lancet 2007;370:797-9. [Ref.ID 80951]
10.Tiene citas relacionadas Cita con resumen
Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368:804-13. [Ref.ID 77961]
11. Cita con resumen
Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367:1618-25. [Ref.ID 76882]
12.
Firestein GS. Inhibiting inflammation in rheumatoid arthritis. N Engl J Med 2006;354:80-2. [Ref.ID 75802]
13. Cita con resumen
Anónimo. Sativex made available in Spain, and hopes rise for use in UK. Scrip 2005;3108:4. [Ref.ID 75449]
14.Tiene citas relacionadas Cita con resumen
McInnes IB, Sattar N, McCarey D, Madhok R, Capell H. Statins and rheumatoid arthritis. Authors' reply. Lancet 2004;364:1855. [Ref.ID 71931]
15.Tiene citas relacionadas Cita con resumen
Kida Y. Statins and rheumatoid arthritis. Lancet 2004;364:1854-5. [Ref.ID 71930]
16.
Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman A B. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-42. [Ref.ID 71848]
17.
Thadani SM, Foster CS. Treatment of ocular inflammation in children. Pediatr Drugs 2004;6:289-301. [Ref.ID 71676]
18. Cita con resumen
Barnes P, Hansel TT. Prospects for new drugs for chronic obstructive pulmonary disease. Lancet 2004;364:985-96. [Ref.ID 71326]
19.Tiene citas relacionadas Cita con resumen
McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakova O, Ford I, Capell HA, Sattar N. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet 2004;363:2015-21. [Ref.ID 70480]
20.Tiene citas relacionadas Cita con resumen
Klareskog L, Hamsten A. Statins in rheumatoid arthritis - two birds with one stone?. Lancet 2004;363:2011-2. [Ref.ID 70477]
Seleccionar todas
 
 1 a 20 de 50 siguiente >>